Cargando…

Thermal Boost Combined with Interstitial Brachytherapy in Early Breast Cancer Conserving Therapy—Initial Group Long-Term Clinical Results and Late Toxicity

(1) In breast-conserving therapy (BCT), adjuvant radiation, including tumor bed boost, is mandatory. Safely delivered thermal boost (TB) based on radio-sensitizing interstitial microwave hyperthermia (MWHT) preceding standard high-dose-rate (HDR) brachytherapy (BT) boost has the potential for local...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chicheł, Adam, Burchardt, Wojciech, Chyrek, Artur J., Bielęda, Grzegorz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504368/ https://www.ncbi.nlm.nih.gov/pubmed/36143167 http://dx.doi.org/10.3390/jpm12091382

Ejemplares similares

Reducing dysphagia with palliative 2D high-dose-rate brachytherapy improves survival in esophageal cancer
por: Burchardt, Wojciech, et al.
Publicado: (2019)

Adjuvant interstitial three-dimensional pulse-dose-rate-brachytherapy for lip squamous cell carcinoma after surgical resection
por: Chyrek, Artur Jan, et al.
Publicado: (2019)

High-dose-rate brachytherapy of primary cutaneous B-cell lymphoma: the first reported case series
por: Chyrek, Artur J., et al.
Publicado: (2020)

Thermal Boost to Breast Tumor Bed—New Technique Description, Treatment Application and Example Clinical Results
por: Chicheł, Adam, et al.
Publicado: (2022)

The potential of low-dose-rate brachytherapy with iodine-125 in the treatment of local recurrences of prostate cancer after primary high-dose-rate monotherapy
por: Burchardt, Wojciech M., et al.
Publicado: (2023)

Superficial high-dose-rate brachytherapy for primary tumors and relapses after surgery in patients with basal cell carcinoma of the head and neck region: results of a retrospective comparative cohort study
por: Chyrek, Artur J., et al.
Publicado: (2022)

3D printing of individual skin brachytherapy applicator: design, manufacturing, and early clinical results
por: Bielęda, Grzegorz, et al.
Publicado: (2022)

Advanced non-melanoma skin cancer in elderly patients: When surgery says NO, interventional radiotherapy (brachytherapy) says YES
por: Chicheł, Adam, et al.
Publicado: (2023)

High-dose-rate surface brachytherapy as a treatment option for renal cell carcinoma cutaneous metastases
por: Raszewski, Łukasz, et al.
Publicado: (2021)

Interstitial high-dose-rate brachytherapy as a boost in synchronous prostate and rectal cancer treatment: case report and literature review
por: Konat-Bąska, Katarzyna, et al.
Publicado: (2020)

Comparison of two techniques of interstitial pulsed dose rate boost brachytherapy in conservative treatment of breast cancer
por: Serkies, Krystyna, et al.
Publicado: (2009)

Quality Assurance Procedures based on Dosimetric, Gamma Analysis as a Fast Reliable Tool for Commissioning Brachytherapy Treatment Planning Systems
por: Zwierzchowski, Grzegorz, et al.
Publicado: (2017)

Interstitial high-dose rate brachytherapy as boost for anal canal cancer
por: Falk, Alexander Tuan, et al.
Publicado: (2014)

Image-guided interstitial brachytherapy boost for nasopharyngeal carcinoma: technical aspects
por: Murakami, Naoya, et al.
Publicado: (2020)

Film based verification of calculation algorithms used for brachytherapy planning-getting ready for upcoming challenges of MBDCA
por: Zwierzchowski, Grzegorz, et al.
Publicado: (2016)

The Efficacy and Late Toxicities of Computed Tomography-based Brachytherapy with Intracavitary and Interstitial Technique in Advanced Cervical Cancer
por: Dang, Yun-Zhi, et al.
Publicado: (2018)

Personalized Superficial HDR Brachytherapy—Dosimetric Verification of Dose Distribution with Lead Shielding of Critical Organs in the Head and Neck Region
por: Zwierzchowski, Grzegorz, et al.
Publicado: (2022)

Dosimetric assessment of the impact of low-cost materials used in stereolithography in high-dose-rate brachytherapy
por: Bielęda, Grzegorz, et al.
Publicado: (2021)

HDR and PDR (192)Ir source activity control procedures, as the part of the quality assurance system at Brachytherapy Department of Greater Poland Cancer Centre
por: Zwierzchowski, Grzegorz, et al.
Publicado: (2009)

Endoscope-Guided Interstitial Intensity-Modulated Brachytherapy and Intracavitary Brachytherapy as Boost Radiation for Primary Early T Stage Nasopharyngeal Carcinoma
por: Wan, Xiang-Bo, et al.
Publicado: (2014)

Brachytherapy in breast cancer: an effective alternative
por: Skowronek, Janusz, et al.
Publicado: (2014)

Overall Survival and Related Factors of Patients Undergoing Breast-Conserving Surgery with Boost Through Interstitial Brachytherapy in a Cancer Center in Medellin, Colombia
por: González-Hernández, Liza María, et al.
Publicado: (2023)

Correlation between treatment plan parameters and particular prognostic factors in prostate cancer treated with high–dose–rate brachytherapy (HDR–BT) as a boost
por: Chicheł, Adam, et al.
Publicado: (2009)

External beam boost versus interstitial high-dose-rate brachytherapy boost in the adjuvant radiotherapy following breast-conserving therapy in early-stage breast cancer: a dosimetric comparison
por: Terheyden, Martje Marie, et al.
Publicado: (2016)

Image-guided interstitial brachytherapy boost for keratinizing squamous cell carcinoma of inferior wall of the nasopharynx
por: Murakami, Naoya, et al.
Publicado: (2020)

Time to PSA rise differentiates the PSA bounce after HDR and LDR brachytherapy of prostate cancer
por: Burchardt, Wojciech, et al.
Publicado: (2018)

Comparison and verification of the reconstruction method of the catheters for interstitial brachytherapy
por: Blasiak, Barbara, et al.
Publicado: (2009)

Ruthenium brachytherapy for iris melanoma
por: Zwolin´ska, Emilia, et al.
Publicado: (2023)

Initial tumor volume as an important predictor for indication of intra-cavitary brachytherapy, intra-cavitary/interstitial brachytherapy, and multi-catheter sole interstitial brachytherapy in cervical cancer patients treated with chemoradiotherapy
por: Takenaka, Tadashi, et al.
Publicado: (2023)

Pulsed-dose-rate peri-operative brachytherapy as an interstitial boost in organ-sparing treatment of breast cancer
por: Serkies, Krystyna, et al.
Publicado: (2016)

Technical report: a high-dose-rate interstitial brachytherapy boost for residual sinonasal undifferentiated carcinoma
por: Miyata, Yusaku, et al.
Publicado: (2022)

Predicting toxicity caused by high-dose-rate brachytherapy single boost for prostate cancer
por: Olsén, Johan Staby, et al.
Publicado: (2022)

High-dose-rate Interstitial Brachytherapy Boost with a Pedicled Latissimus Dorsi Myocutaneous Flap for Myxofibrosarcoma of the Arm
por: Lane, Jordan D., et al.
Publicado: (2014)

Per-oral interstitial brachytherapy catheter insertion for boost in case of recurrent tonsillar carcinoma: dosimetry and clinical outcome
por: Murakami, Naoya, et al.
Publicado: (2020)

Dosimetric comparison between interstitial brachytherapy and volumetric-modulated arc therapy for tumor bed boost in breast cancer
por: Periasamy, Kannan, et al.
Publicado: (2021)

Breast conservation therapy without capsular contracture in young augmented women using interstitial brachytherapy
por: Kuske, Robert
Publicado: (2014)

Interstitial Brachytherapy for Orbital Sebaceous Carcinoma
por: Li, Feng, et al.
Publicado: (2021)

Postoperative interstitial brachytherapy in eyelid cancer: long term results and assessment of Cosmesis After Interstitial Brachytherapy scale
por: Laskar, Sarbani Ghosh, et al.
Publicado: (2014)

HDR brachytherapy of prostate cancer – two years experience in Greater Poland Cancer Centre
por: Kanikowski, Marek, et al.
Publicado: (2009)

Vital role of volume and number of needles in HDR brachytherapy (HDR-BT) of prostate cancer
por: Chicheł, Adam, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_j3vjp3b7v624m90imtcf87o5g5